GAINES; Simon
Patent Applications and Registrations
Patent applications and USPTO patent grants for GAINES; Simon.The latest application filed is for "compound having kdm5 inhibitory activity and pharmaceutical use thereof".
- GAINES; Simon - Saffron Walden GB
- Gaines; Simon - Harlow GB
- Gaines; Simon - Stevenage N/A GB
- Gaines; Simon - Hertfordshire GB
| Patent | Date |
|---|---|
| Compound Having Kdm5 Inhibitory Activity And Pharmaceutical Use Thereof App 20220289751 - KAKUUCHI; Akito ; et al. | 2022-09-15 |
| Aryl sultam derivatives as RORc modulators Grant 10,131,644 - van Niel , et al. November 20, 2 | 2018-11-20 |
| Aryl sultam derivatives as RORc modulators Grant 9,751,873 - Fauber , et al. September 5, 2 | 2017-09-05 |
| ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20170137393 - van Niel; Monique Bodil ; et al. | 2017-05-18 |
| Benzyl sulfonamide derivatives as RORc modulators Grant 9,382,222 - Fauber , et al. July 5, 2 | 2016-07-05 |
| ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20160168141 - Fauber; Benjamin ; et al. | 2016-06-16 |
| Aryl sultam derivatives as RORc modulators Grant 9,115,101 - Bodil van Niel , et al. August 25, 2 | 2015-08-25 |
| ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20150197529 - Fauber; Benjamin ; et al. | 2015-07-16 |
| Compounds Grant 8,765,743 - Baldwin , et al. July 1, 2 | 2014-07-01 |
| BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS App 20140163024 - Fauber; Benjamin ; et al. | 2014-06-12 |
| Benzpyrazol derivatives as inhibitors of PI3 kinases Grant 8,658,635 - Baldwin , et al. February 25, 2 | 2014-02-25 |
| ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20140031330 - Bodil van Niel; Monique ; et al. | 2014-01-30 |
| Compounds Grant 8,536,169 - Baldwin , et al. September 17, 2 | 2013-09-17 |
| Novel Use App 20130165433 - Baldwin; Ian Robert ; et al. | 2013-06-27 |
| Matrix metalloproteinase inhibitors Grant 8,343,986 - Gaines , et al. January 1, 2 | 2013-01-01 |
| Benzpyrazole Derivatives As Inhibitors Of Pi3 Kinases App 20120245171 - Baldwin; Ian Robert ; et al. | 2012-09-27 |
| Novel Compounds App 20120238559 - Baldwin; Ian Robert ; et al. | 2012-09-20 |
| Indazole Derivatives As Pi 3-kinase App 20120238571 - Baldwin; Ian Robert ; et al. | 2012-09-20 |
| Matrix metalloproteinase inhibitors Grant 8,263,602 - Gaines , et al. September 11, 2 | 2012-09-11 |
| 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases Grant 8,163,743 - Baldwin , et al. April 24, 2 | 2012-04-24 |
| Novel Compounds App 20110183973 - Baldwin; Ian Robert ; et al. | 2011-07-28 |
| Benzpyrazol Derivatives As Inhibitors Of Pi3 Kinases App 20110178063 - Baldwin; Ian Robert ; et al. | 2011-07-21 |
| Novel Compounds App 20110118246 - Baldwin; Ian Robert ; et al. | 2011-05-19 |
| 4-carboxamide Indazole Derivatives Useful As Inhibitors Of P13-kinases App 20110112070 - Baldwin; Ian Robert ; et al. | 2011-05-12 |
| Matrix Metalloproteinase Inhibitors App 20100029699 - Gaines; Simon ; et al. | 2010-02-04 |
| Matrix metalloproteinase inhibitors Grant 7,601,729 - Gaines , et al. October 13, 2 | 2009-10-13 |
| Matrix Metalloproteinase Inhibitors App 20090082377 - Gaines; Simon ; et al. | 2009-03-26 |
| Matrix metalloproteinase inhibitors Grant 7,250,439 - Gaines , et al. July 31, 2 | 2007-07-31 |
| Matrix metalloproteinase inhibitors App 20060293353 - Gaines; Simon ; et al. | 2006-12-28 |
| Matrix metalloproteinase inhibitors App 20060160875 - Gaines; Simon ; et al. | 2006-07-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 